Coeur d'Alene

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Liver and biliary tract cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Withdrawn1 trial

Lead sponsor

• AstraZeneca3 trials

Running trials

• Active, not recruiting

  Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

  NCT04999969· Phase 2· AstraZeneca· Source

• Active, not recruiting

  Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin

  NCT04960709· Phase 3· AstraZeneca· Source

Closed trials

• Recruiting

  Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

  NCT06467357· Phase 3· AstraZeneca· Source